FEATURED

Bosutinib: Management of Adverse Events

Managing adverse effects after starting a TKI can be challenging, and health care practitioners often look to CML experts for guidance.

Risk of Blood Cancers After Chemotherapy

For 22 of 23 solid cancers investigated in a new study, the risk of therapy-related myelodysplastic syndrome or acute myeloid leukemia increases after chemotherapy.

Fact Sheet: Fermented Dairy and Cancer

This fact sheet describes the potential relationship between fermented dairy intake and cancer.

Predictions in Medicine 2019: What's Ahead

A new partner in the fight to cure cancer. A once-unlikely source for combatting clinician burnout. These are some of the advances we and other experts predict will affect oncologists and their patients in 2019 and beyond. Take a look inside our crystal ball.

Ask the Experts: NSCLC

Cancer Therapy Advisor asked 2 experts to weigh in on recommended treatment modalities for patients with non-small cell lung cancer.

Ask the Experts: STS Clinical Insights

Cancer Therapy Advisor asked 2 experts to weigh in on the latest clinical insights into soft tissue sarcoma.

Ask the Experts: Waldenström Macroglobulinemia

Cancer Therapy Advisor asked 3 experts to weigh in on recommended treatment modalities for patients with Waldenström macroglobulinemia.

Looking for a Job?

Access our job board to view over 1,​200 job openings throughout the US.

Treatment Regimens

A full listing of cancer treatment and drug information is available to access.

Latest Features

Bosutinib: Management of Adverse Events in Chronic Myeloid Leukemia

Bosutinib: Management of Adverse Events in Chronic Myeloid Leukemia

Managing adverse effects after starting a TKI can be challenging, and health care practitioners often look to CML experts for guidance.

Risk of Rare Blood Cancers Rises After Solid Tumor Chemotherapy

Risk of Rare Blood Cancers Rises After Solid Tumor Chemotherapy

For 22 of 23 solid cancers investigated in a new study, the risk of therapy-related myelodysplastic syndrome or acute myeloid leukemia increases after chemotherapy.

SURTIME Trial: Surgery May Not Be Most Appropriate Frontline Treatment in mRCC

SURTIME Trial: Surgery May Not Be Most Appropriate Frontline Treatment in mRCC

Evidence suggests that starting on systemic drug therapy immediately may be the best approach for some patients with metastatic RCC.

Increased Risk of Myeloma in African Americans Driven By Higher Rates of 3 Disease Subtypes

Increased Risk of Myeloma in African Americans Driven By Higher Rates of 3 Disease Subtypes

Three specific subtypes of multiple myeloma were found to drive higher incidence rates among individuals of African descent.

Evidence Grows Linking BIA-ALCL to Textured Surface of Some Breast Implants

Evidence Grows Linking BIA-ALCL to Textured Surface of Some Breast Implants

Europe halts sales of textured breast implants as more studies demonstrate a link between this type of implant and the development of a rare lymphoma.

Sign Up for Free e-newsletters



Regimen and Drug Listings

GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION

Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Prostate Cancer Regimens Drugs
Rare Cancers Regimens
Renal Cell Carcinoma Regimens Drugs
Skin Cancer Regimens Drugs
Urologic Cancers Regimens Drugs